AUT00206: Ph Ib started

Autifony began a double-blind, 4-way crossover, U.K. Phase Ib trial of oral AUT00206 in about 16 healthy male volunteers. Subjects will receive 800 or 2,000 mg AUT00206 or placebo during a ketamine ch...